Global Peptide Therapeutics Market

Transcription

1 Brochure More information from Global Peptide Therapeutics Market Description: About Peptide Therapeutics Peptides are amino acids sequences and among the most potent biologically active substances found in nature. Peptides are used to control, trigger, and maintain physiological processes in living beings. However, the use of peptides as therapeutic agents has always been difficult because of their inherent instability and incapability to cross cellular membranes. Peptides also entail the requirement of specific technology to tackle the extensive and challenging steps in their synthesis. Currently, there are more than 80 peptides marketed by various companies. These companies explore the probability of designing and engineering peptides that overcome their natural confines and allow these potent chemical entities to be used as therapeutic agents. The analysts forecast the Global Peptide Therapeutics market to grow at a CAGR of 9.25 percent over the period Covered in this Report This report covers the present scenario and the growth prospects of the Global Peptide Therapeutics market for the period To calculate the market size, the report considers revenue generated through the sales of various approved peptide drugs to treat individuals against various diseases, such as, cardiovascular, metabolic, neurological, respiratory, and others. The report, the Global Peptide Therapeutics Market , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Peptide Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions - Americas - EMEA - APAC Key Vendors - AstraZeneca - Eli Lilly - Novo Nordisk - Sanofi Other Prominent Vendors - Abbvie - Advanced Accelerator Applications - Akashi Therapeutics - Amylin - Anthera Pharmaceuticals - AstraZeneca - Bachem - Bristol Myers Squibb - Cardiorentis - Cubist Pharmaceuticals - Diartis Pharmaceuticals - Debiopharm - Derma Sciences - GlaxoSmithKline - Hanmi Pharmaceutical - Insmed - Ipsen - Johnson & Johnson - Lonza

2 - Mallinckrodt - MolMed - Merck - Novartis - Nymox Pharmaceutical - Par Pharmaceuticals - PeptiDream - Peptisyntha - Polypeptide Group - Radius Health - Repligen - SciClone - Shire - Takeda Pharmaceutical - The Medicines Company - Transition Therapeutics - X-Gen Pharmaceuticals - Zealand Pharma - Zydus Cadila Market Drivers - Rising Patient Population - For a full, detailed list, view our report Market Challenges - High Cost of Therapy - For a full, detailed list, view our report Market Trends - Growing Popularity - For a full, detailed list, view our report Key Questions Answered in this Report - What will the market size be in 2018 and what will the growth rate be? - What are the key Market Trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? The report is also available as part of our annual subscription offer. Please get in touch with our customers service team in order to find out more. Contents: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Market Segmentation by Route of Administration 07.1 Parenteral 07.2 Oral

3 07.3 Pulmonary 07.4 Mucosal 08. Market Segmentation by Drug Class 08.1 Somatostatins 08.2 Vasopressins 08.3 Calcitonins 08.4 LHRH 08.5 Glucagon and Analogs 08.6 Insulins 08.7 Others 09. Market Segmentation by Technology 09.1 Liquid Phase Peptide Synthesis 09.2 Solid Phase Peptide Synthesis 09.3 Hybrid Synthesis 10. Geographical Segmentation 10.1 Peptide Therapeutics Market in the Americas Market Size and Forecast 10.2 Peptide Therapeutics Market in the EMEA Market Size and Forecast 10.3 Peptide Therapeutics Market in APAC Market Size and Forecast 11. Peptide Synthesis 12. Optimization of Peptides 12.1 Ligation 12.2 Cyclization 12.3 Heterodimerization 12.4 Cytoconjugation 13. Stabilization of Peptides 13.1 Stapled Peptides 13.2 Disulfide-rich Peptides 13.3 Other Constrained Peptides 14. Buying Criteria 15. Market Growth Drivers 16. Drivers and their Impact 17. Market Challenges 18. Impact of Drivers and Challenges 19. Market Trends 20. Trends and their Impact 21. Vendor Landscape 21.1 Competitive Scenario Key News Mergers and Acquisitions 21.2 Market Share Analysis Other and Future Prominent Vendors 22. Pipeline Portfolio 23. Key Vendor Analysis 23.1 AstraZeneca Key Facts Business Description Business Segmentation Business Strategy Revenue by Business Segmentation Revenue Comparison Sales Revenue by Geographical Segmentation Key Developments SWOT Analysis 23.2 Eli Lilly Key Facts Business Overview Business Segmentation by Revenue Business Segmentation by Revenue 2012 and Sales by Geography Business Strategy

4 Key Developments SWOT Analysis 23.3 Novo Nordisk Key Facts Business Overview Business Segmentation Business Strategy Revenue Segmentation by Business Revenue Comparison by Business Segments 2012 and Sales by Geography Key Information SWOT Analysis 23.4 Sanofi Key Facts Business Overview Business Segmentation by Revenue Business Segmentation by Revenue 2012 and Geographical Segmentation by Revenue Business Strategy Key Developments SWOT Analysis 24. Other Reports in this Series List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global Peptide Therapeutics Market (US$ billion) Exhibit 3: Global Peptide Therapeutics Market Segmentation by Route of Administration Exhibit 4: Global Peptide Therapeutics Market Segmentation by Route of Administration 2013 Exhibit 5: Global Peptide Therapeutics Market Segmentation by Class of Drugs Exhibit 6: Global Peptide Therapeutics Market Segmentation by Technology Exhibit 7: Global Peptide Therapeutics Market by Geographical Segmentation 2013 Exhibit 8: Peptide Therapeutics Market in Americas (US$ billion) Exhibit 9: Peptide Therapeutics Market in EMEA (US$ billion) Exhibit 10: Peptide Therapeutics Market in APAC (US$ billion) Exhibit 11: Steps involved in Peptide Synthesis Exhibit 12: Optimization of Peptide Synthesis Exhibit 13: Methods used for Stabilization of Peptides Exhibit 14: Global Peptide Therapeutics Market Segmentation 2013 Exhibit 15: Therapeutic Areas for Peptides in Clinical Studies 2013 Exhibit 16: Peptide Therapeutics in Phase III Clinical Trials, 2013 Exhibit 17: Peptide Therapeutics Under Clinical Trials According to MOA Exhibit 18: AstraZeneca: Business Segmentation Exhibit 19: AstraZeneca: Revenue by Business Segmentation 2013 Exhibit 20: AstraZeneca: Revenue by Business Segmentation (US$ billion) Exhibit 21: AstraZeneca: Sales Revenue by Geographical Segmentation 2013 Exhibit 22: Eli Lilly and Co.: Business Segmentation by Revenue 2013 Exhibit 23: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million) Exhibit 24: Eli Lilly and Co.: Sales by Geography 2013 Exhibit 25: Business Segments of Novo Nordisk A/S 2013 Exhibit 26: Novo Nordisk A/S: Business Segmentation 2013 Exhibit 27: Novo Nordisk A/S: Revenue Comparison 2012 and 2013 (US$ billion) Exhibit 28: Novo Nordisk A/S: Sales by Geography 2013 Exhibit 29: Sanofi: Business Segmentation by Revenue 2013 Exhibit 30: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million) Exhibit 31: Sanofi: Geographical Segmentation by Revenue 2013 Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to

5 Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

6 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Global Peptide Therapeutics Market Web Address: Office Code: Product Formats Please select the product formats and quantity you require: SC Electronic (PDF) - Single User: Electronic (PDF) Users: Electronic (PDF) - Site License: Electronic (PDF) - Enterprisewide: Quantity USD 2000 USD Until 15th Jan 2016 USD 2240 USD Until 15th Jan 2016 USD 2800 USD Until 15th Jan 2016 USD 8000 USD Until 15th Jan 2016 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number:

7 Page 1 of 2 Title: Mr Mrs Dr Miss Ms Prof * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

8 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World